RESUMO
Hantaviruses are emerging human pathogens. They induce an unusually strong antiviral response of human HLA class I (HLA-I) restricted CD8⺠T cells that may contribute to tissue damage and hantavirus-associated disease. In this study, we analyzed possible hantaviral mechanisms that enhance the HLA-I antigen presentation machinery. Upon hantavirus infection of various human and primate cell lines, we observed transactivation of promoters controlling classical HLA molecules. Hantavirus-induced HLA-I upregulation required proteasomal activity and was associated with increased TAP expression. Intriguingly, human DCs acquired the capacity to cross-present antigen upon hantavirus infection. Furthermore, knockdown of TIR domain containing adaptor inducing IFN-ß or retinoic acid inducible gene I abolished hantavirus-driven HLA-I induction. In contrast, MyD88-dependent viral sensors were not involved in HLA-I induction. Our results show that hantaviruses strongly boost the HLA-I antigen presentation machinery by mechanisms that are dependent on both retinoic acid inducible gene I and TIR domain containing adaptor inducing IFN-ß.
Assuntos
Proteínas Adaptadoras de Transporte Vesicular/metabolismo , Apresentação de Antígeno , Células Dendríticas/imunologia , Infecções por Hantavirus/imunologia , Orthohantavírus/imunologia , Receptores do Ácido Retinoico/metabolismo , Transportadores de Cassetes de Ligação de ATP/metabolismo , Proteínas Adaptadoras de Transporte Vesicular/genética , Animais , Chlorocebus aethiops , Apresentação Cruzada/genética , Células Dendríticas/virologia , Antígenos HLA/genética , Antígenos HLA/metabolismo , Humanos , Complexo de Endopeptidases do Proteassoma/metabolismo , RNA Interferente Pequeno/genética , Receptores do Ácido Retinoico/genética , Regulação para Cima , Células VeroRESUMO
SUMMARY: Hantaviruses are predominantly rodent-borne pathogens, although recently novel shrew-associated hantaviruses were found. Within natural reservoir hosts, hantairuses do not cause obvious pathogenetic effects; transmission to humans, however, can lead to hemorrhagic fever with renal syndrome or hantavirus cardiopulmonary syndrome, depending on the virus species involved. This review is focussed on the recent knowledge on hantavirus-induced immune responses in rodent reservoirs and humans and their impact on susceptibility, transmission, and outcome of hantavirus infections. In addition, this review incorporates a discussion on the potential role of direct cell-virus interactions in the pathogenesis of hantavirus infections in humans. Finally, questions for further research efforts on the immune responses in potential hantavirus reservoir hosts and humans are summarized.
Assuntos
Células Dendríticas/imunologia , Reservatórios de Doenças/virologia , Infecções por Hantavirus/imunologia , Orthohantavírus/fisiologia , Subpopulações de Linfócitos T/imunologia , Animais , Anticorpos Antivirais/imunologia , Anticorpos Antivirais/metabolismo , Apoptose/imunologia , Células Dendríticas/metabolismo , Orthohantavírus/genética , Orthohantavírus/imunologia , Infecções por Hantavirus/patologia , Infecções por Hantavirus/transmissão , Infecções por Hantavirus/virologia , Humanos , Imunidade Ativa , Imunidade Inata , Integrinas/imunologia , Integrinas/metabolismo , Roedores/imunologia , Roedores/virologia , Subpopulações de Linfócitos T/metabolismo , Fator A de Crescimento do Endotélio Vascular/imunologia , Fator A de Crescimento do Endotélio Vascular/metabolismoRESUMO
Hantavirus infection can cause hantavirus cardiopulmonary syndrome or hemorrhagic fever with renal syndrome depending on the virus species involved. The determinants for the virus species specific virulence in humans are unclear. Successful infection is a conditio sine qua non for the virulence of a virus and it is well-known that the innate interferon (IFN) system generally plays a decisive role to prevent establishment of an infection. The importance of the IFN system is underscored by the fact that viruses have developed an amazing number of different escape mechanisms to enable replication in face of the antiviral host response. Interestingly, pathogenic hantaviruses escape induction of innate antiviral responses in the early phase of the infection, which are elicited in a pronounced manner by nonpathogenic hantaviruses in vitro. This differential response might be important for the pathogenicity of hantaviruses in humans. This review aims to summarize the current knowledge about the interaction between hantaviruses and the innate IFN system. Detailed characterization of the cellular sensors and pathways that lead to activation of the IFN system on one side and the viral escape mechanisms on the other might help to develop novel vaccination strategies and therapeutic approaches.
Assuntos
Imunidade Inata , Orthohantavírus/imunologia , Animais , Genoma , Humanos , Interferons/imunologia , Vacinas Virais/imunologiaRESUMO
Immediately after viral infection, innate responses including expression of IFN-alpha/beta and IFN-stimulated genes (ISGs) are elicited ubiquitously by recruitment of specific pathogen recognition receptors. The velocity to induce IFN-alpha/beta and ISGs in response to an infection is often decisive for virulence. Interestingly, in primary endothelial cells ISGs are induced later by hantaviruses pathogenic to humans than those considered to be nonpathogenic or of low virulence. Here we demonstrate that pathogenic Hantaan (HTNV) and putatively nonpathogenic Prospect Hill hantavirus (PHV) differentially activate innate responses in the established cell lines A549 and HuH7. STAT1alpha phosphorylation was detectable 3 h after PHV inoculation but not within the first 2 days after HTNV inoculation. The velocity to induce the ISGs MxA and ISG15 correlated inversely with amounts of virus produced. Moreover, expression of the inflammatory chemokine CCL5 was also induced differentially. Both hantaviruses induced innate responses via TRAF3 (TNF receptor-associated factor 3), and TLR3 was required for HTNV-induced expression of MxA, but not for the MxA induction triggered by PHV. Infection of RIG-I-deficient HuH7.5 cells revealed that RIG-I (retinoic acid receptor I) was not necessary for induction of innate responses by PHV. Taken together, these data suggest that HTNV and PHV elicit different signaling cascades that converge via TRAF3. Early induction of antiviral responses might contribute to efficient elimination of PHV. Subsequent to clearance of the infection, innate responses most likely cease; vice versa, retarded induction of antiviral responses could lead to increased HTNV replication and dissemination, which might cause a prolonged inflammatory response and might contribute to the in vivo virulence.
Assuntos
Regulação Viral da Expressão Gênica/imunologia , Vírus Hantaan/imunologia , Imunidade Inata , Receptor 3 Toll-Like/fisiologia , Ativação Viral/imunologia , Animais , Linhagem Celular Transformada , Linhagem Celular Tumoral , Quimiocina CCL5/biossíntese , Quimiocina CCL5/genética , Chlorocebus aethiops , Citocinas/fisiologia , Proteína DEAD-box 58 , RNA Helicases DEAD-box/fisiologia , Proteínas de Ligação ao GTP/biossíntese , Proteínas de Ligação ao GTP/genética , Vírus Hantaan/patogenicidade , Humanos , Interferon-alfa/fisiologia , Interferon beta/fisiologia , Proteínas de Resistência a Myxovirus , Receptores Imunológicos , Fator de Transcrição STAT2/fisiologia , Transdução de Sinais/imunologia , Fator 3 Associado a Receptor de TNF/fisiologia , Ubiquitinas/fisiologia , Células Vero , Replicação Viral/imunologiaRESUMO
Increased vascular permeability is a key feature of the pathological symptoms caused by hantaviruses. Here, we analysed the interaction between hantaviruses and mast cells, which regulate vascular homeostasis. In highly purified human skin mast cells increasing amounts of Hantaan (HTNV) and, to a lower extent, Prospect Hill (PHV) virions were produced. Replication was confirmed by the production of viral plus-strand RNA as determined by a virus strand-specific RT-PCR. PHV but not HTNV elicited early expression of beta interferon, MxA, ISG15 and CCL5 consistent to studies with other cell types. The data demonstrate that mature mast cells are permissive to infection with hantaviruses. This interaction might contribute to the development of vascular leakage syndrome.
Assuntos
Mastócitos/virologia , Orthohantavírus/fisiologia , Replicação Viral , Células Cultivadas , Quimiocina CCL5/biossíntese , Citocinas/biossíntese , Proteínas de Ligação ao GTP/biossíntese , Expressão Gênica , Humanos , Interferon beta/biossíntese , Proteínas de Resistência a Myxovirus , RNA Viral/biossíntese , RNA Viral/genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Ubiquitinas/biossínteseRESUMO
Hantaviruses belong to the family Bunyaviridae characterized by tri-segmented RNA genomes. Depending on the hantavirus species, infection can lead to hantavirus cardiopulmonary or haemorrhagic fever with renal syndrome. In vitro studies suggest that pathogenic hantaviruses evade induction of innate antiviral responses, and this ability might determine the virulence in humans. Since reverse genetic systems are not available, in vitro reassortment is currently the only way to culture defined hantavirus variants. Here, we demonstrate for the first time the generation of a reassortant between a pathogenic Old World and a non-pathogenic New World hantavirus in vitro. The reassortant contained the glycoprotein coding M-segment derived from the pathogenic Puumala virus (PUUV) and the other genomic segments coding for the nucleocapsid protein and RNA-dependent RNA-polymerase from Prospect Hill virus (PHV), which is taken as non-pathogenic in humans. Exchange of the M-segment was confirmed by sequencing and virus neutralization test with PUUV-specific sera. Functional analysis of the reassortant and parental viruses revealed characteristic growth kinetics and innate immune responses as determined by expression analyses for lambda interferon and MxA, and by interferon-stimulated response element reporter gene studies. Consistent with previous studies with other pathogenic hantaviruses, PUUV elicited reduced innate responses if compared with PHV. In all these functional assays the reassortant revealed PHV-like phenotypes. Thus, neither the PUUV M-segment nor entry via specific M-segment directed pathways modulated the virus type-specific innate responses. Moreover, the data imply that this approach might be an option for production of attenuated viruses that could be used as vaccines against pathogenic hantaviruses.
Assuntos
Orthohantavírus/genética , Virus Puumala/genética , Vírus Reordenados/genética , Animais , Linhagem Celular , Chlorocebus aethiops , Proteínas de Ligação ao GTP/genética , Orthohantavírus/imunologia , Orthohantavírus/patogenicidade , Orthohantavírus/fisiologia , Humanos , Imunidade Inata , Técnicas In Vitro , Interferons/genética , Proteínas de Resistência a Myxovirus , Testes de Neutralização , Filogenia , Virus Puumala/imunologia , Virus Puumala/patogenicidade , Virus Puumala/fisiologia , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Vírus Reordenados/imunologia , Vírus Reordenados/patogenicidade , Vírus Reordenados/fisiologia , Especificidade da Espécie , Células Vero , Virulência/genética , Virulência/imunologia , Replicação Viral/genéticaRESUMO
The tri-segmented RNA genome of hantaviruses facilitates genetic reassortment by segment swapping when cells are co-infected with different virus strains. We found efficient in vitro reassortment between members of two different genetic lineages of the Dobrava-Belgrade virus species, the weakly virulent DOBV-Aa and highly virulent DOBV-Af. In all reassortants, S and L segments originated from the same parental strain, and only the M segment was exchanged. To identify functional differences between the parental strains DOBV-Aa and DOBV-Af in cell culture and to compare them with the reassortants, we studied elements of the innate immunity in virus-infected cells. The contrasting phenotypes of the parental viruses were maintained by the reassortants carrying the respective S and L segments of the parental virus and were not influenced by the origin of the M segment.
Assuntos
Infecções por Hantavirus/virologia , Orthohantavírus/genética , Vírus Reordenados/genética , Recombinação Genética , Animais , Linhagem Celular , Chlorocebus aethiops , Orthohantavírus/classificação , Orthohantavírus/imunologia , Orthohantavírus/patogenicidade , Infecções por Hantavirus/imunologia , Humanos , Dados de Sequência Molecular , Vírus Reordenados/classificação , Vírus Reordenados/imunologia , Vírus Reordenados/patogenicidade , Células Vero , Proteínas Virais/genética , VirulênciaRESUMO
OBJECTIVE: Stocks of RNA viruses often contain divergent mixtures of infectious and defective particles (DPs). Since the surface of both particles share the same immunoreactivity, differing ratios of these particles in stocks used for virus neutralization tests might alter the results. Here the impact of such off-target effects were measured. METHODS: To determine the relative content of DPs in 3 stocks with high, medium and low titers of infectious virions, the amounts of nucleocapsid protein and viral RNA were quantified by Western blot and quantitative RT-PCR. Thereafter, stocks with different amount of DPs were used to determine the titer of neutralizing antibodies in serum from a convalescent Puumala virus-infected patient by a focus reduction neutralization test. RESULTS: The relative amount of DPs was at least 5-fold higher in the stock with the lowest titer compared to the stock with the highest. Stocks with lower levels of DPs led to higher antibody titers compared to the analysis performed with stocks containing higher levels of DPs. CONCLUSION: These results imply that DPs in virus stocks should be considered when performing virus neutralization tests to quantify neutralizing antibodies.
Assuntos
Anticorpos Neutralizantes/imunologia , Vírus Defeituosos/imunologia , Animais , Anticorpos Neutralizantes/sangue , Anticorpos Antivirais/sangue , Anticorpos Antivirais/imunologia , Western Blotting , Chlorocebus aethiops , Febre Hemorrágica com Síndrome Renal/sangue , Febre Hemorrágica com Síndrome Renal/diagnóstico , Febre Hemorrágica com Síndrome Renal/imunologia , Humanos , Testes de Neutralização , Proteínas do Nucleocapsídeo/genética , Virus Puumala/genética , Virus Puumala/imunologia , RNA Viral/análise , RNA Viral/genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Sensibilidade e Especificidade , Células Vero , Vírion/imunologiaRESUMO
Interferons (IFN) induce an antiviral state against Hantaan virus (HTNV) but the mechanisms responsible for inhibition are unclear. The IFN-inducible MxA is discussed to be important for control of infections with hantaviruses. To characterize the role of endogenous MxA, the inhibition of HTNV induced by type I and type II IFNs was compared in Vero and A549 cells. IFNalpha and IFNgamma reduced production of infectious virions, viral RNA, and nucleocapsid protein with the same efficiency, although expression of MxA protein was detectable only in IFNalpha-treated A549 cells. Furthermore, knock down of MxA expression did not impair IFNalpha-induced inhibition. Thus, inhibition of HTNV induced by type I and type II IFNs did not dependent on expression of endogenous MxA. Taken together, these data suggest that MxA endogenously expressed in response to type I or type II IFNs does not play a pivotal role for the antiviral state against HTNV and that there is more than one mechanism by which cellular defences block hantavirus replication.
Assuntos
Proteínas de Ligação ao GTP/metabolismo , Interferons/farmacologia , Orthohantavírus/efeitos dos fármacos , Replicação Viral/efeitos dos fármacos , Animais , Chlorocebus aethiops , Orthohantavírus/imunologia , Orthohantavírus/patogenicidade , Orthohantavírus/fisiologia , Interferon Tipo I/sangue , Interferon Tipo I/farmacologia , Interferon gama/sangue , Interferon gama/farmacologia , Proteínas de Resistência a Myxovirus , Células VeroRESUMO
Hantaviruses are rodent-borne pathogens with a segmented single-stranded RNA genome of negative polarity. Spontaneous occurrence of variants with genetic heterogeneity have been observed both in vivo and in vitro. The objective of this study was to establish a method for the cloning of genetically homogenous hantaviruses which can be used for subsequent functional studies. Infected VeroE6 cells were incubated with an agarose/medium overlay to prevent uncontrolled distribution of de novo synthesized virus. Thereafter, the overlay was removed and stored for isolation of the diffused virus. The cell layer was fixed and viral antigen-containing foci were detected by immunochemistry. The relative location of the foci on the culture dish was used to trap individual virus clones in the corresponding overlay. The clones were picked and used for re-infection. According to this novel protocol three different hantaviruses, i.e. Hantaan, Puumala, and Tula virus, were purified. In the course of purification the titers of the resulting virus stocks were increased by 10-1000-fold. In addition, this method was used to purify a minor Puumala virus variant from a parental stock containing a mixture of two variants. Taken together, the method presented is well suited to isolate genetically homogenous hantaviruses and might also be applicable for other non-cytolytic viruses.
Assuntos
Clonagem de Organismos , Orthohantavírus/crescimento & desenvolvimento , Virologia/métodos , Animais , Chlorocebus aethiops , Genoma Viral , Orthohantavírus/genética , Orthohantavírus/isolamento & purificação , RNA Viral/genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Análise de Sequência de DNA , Células Vero , Cultura de Vírus , Replicação ViralRESUMO
Host defense to RNA viruses depends on rapid intracellular recognition of viral RNA by two cytoplasmic RNA helicases: RIG-I and MDA5. RNA transfection experiments indicate that RIG-I responds to naked double-stranded RNAs (dsRNAs) with a triphosphorylated 5' (5'ppp) terminus. However, the identity of the RIG-I stimulating viral structures in an authentic infection context remains unresolved. We show that incoming viral nucleocapsids containing a 5'ppp dsRNA "panhandle" structure trigger antiviral signaling that commences with RIG-I, is mediated through the adaptor protein MAVS, and terminates with transcription factor IRF-3. Independent of mammalian cofactors or viral polymerase activity, RIG-I bound to viral nucleocapsids, underwent a conformational switch, and homo-oligomerized. Enzymatic probing and superresolution microscopy suggest that RIG-I interacts with the panhandle structure of the viral nucleocapsids. These results define cytoplasmic entry of nucleocapsids as the proximal RIG-I-sensitive step during infection and establish viral nucleocapsids with a 5'ppp dsRNA panhandle as a RIG-I activator.
Assuntos
RNA Helicases DEAD-box/imunologia , Nucleocapsídeo/imunologia , Infecções por Vírus de RNA/enzimologia , Infecções por Vírus de RNA/imunologia , Vírus de RNA/imunologia , Proteínas Adaptadoras de Transdução de Sinal/genética , Proteínas Adaptadoras de Transdução de Sinal/imunologia , Proteína DEAD-box 58 , RNA Helicases DEAD-box/química , RNA Helicases DEAD-box/genética , Genoma Viral , Interações Hospedeiro-Patógeno , Humanos , Nucleocapsídeo/química , Nucleocapsídeo/genética , Polifosfatos/metabolismo , Infecções por Vírus de RNA/genética , Infecções por Vírus de RNA/virologia , Vírus de RNA/química , Vírus de RNA/genética , RNA Viral/química , RNA Viral/genética , RNA Viral/imunologia , Receptores Imunológicos , Transdução de SinaisRESUMO
BACKGROUND: Dobrava-Belgrade virus (DOBV) is a European hantavirus causing hemorrhagic fever with renal syndrome (HFRS) in humans with fatality rates of up to 12%. DOBV-associated clinical cases typically occur also in the northern part of Germany where the virus is carried by the striped field mouse (Apodemus agrarius). However, the causative agent responsible for human illness has not been previously isolated. METHODOLOGY/PRINCIPAL FINDINGS: Here we report on characterization of a novel cell culture isolate from Germany obtained from a lung tissue of "spillover" infected yellow necked mouse (A. flavicollis) trapped near the city of Greifswald. Phylogenetic analyses demonstrated close clustering of the new strain, designated Greifswald/Aa (GRW/Aa) with the nucleotide sequence obtained from a northern German HFRS patient. The virus was effectively blocked by specific antibodies directed against ß3 integrins and Decay Accelerating Factor (DAF) indicating that the virus uses same receptors as the highly pathogenic Hantaan virus (HTNV). In addition, activation of selected innate immunity markers as interferon ß and λ and antiviral protein MxA after viral infection of A549 cells was investigated and showed that the virus modulates the first-line antiviral response in a similar way as HTNV. CONCLUSIONS/SIGNIFICANCE: In summary, our study reveals novel data on DOBV receptor usage and innate immunity induction in relationship to virus pathogenicity and underlines the potency of German DOBV strains to act as human pathogen.
Assuntos
Febre Hemorrágica com Síndrome Renal/imunologia , Febre Hemorrágica com Síndrome Renal/virologia , Orthohantavírus/imunologia , Orthohantavírus/isolamento & purificação , Animais , Células CHO , Linhagem Celular , Chlorocebus aethiops , Cricetinae , Genoma Viral , Alemanha , Orthohantavírus/genética , Orthohantavírus/patogenicidade , Humanos , Imunidade Inata , Interferons/imunologia , Camundongos , Filogenia , Células VeroAssuntos
Cavidades Cranianas/patologia , Cavidades Cranianas/parasitologia , Neuroborreliose de Lyme/complicações , Meningite/parasitologia , Trombose dos Seios Intracranianos/patologia , Trombose dos Seios Intracranianos/parasitologia , Adulto , Antibacterianos/farmacologia , Antibacterianos/uso terapêutico , Anticoagulantes , Encéfalo/irrigação sanguínea , Encéfalo/fisiopatologia , Ceftriaxona/farmacologia , Ceftriaxona/uso terapêutico , Cavidades Cranianas/diagnóstico por imagem , Humanos , Angiografia por Ressonância Magnética , Imageamento por Ressonância Magnética , Masculino , Meninges/diagnóstico por imagem , Meninges/parasitologia , Meninges/patologia , Trombose dos Seios Intracranianos/diagnóstico por imagem , Tomografia Computadorizada por Raios X , Resultado do TratamentoRESUMO
It is well established that interferon-alpha can induce non-cytotoxic intracellular suppression of hepatitis B virus replication, but the mechanisms involved are unclear. Cell culture studies to characterize these mechanisms are restricted, in part because hepatitis B virus replicates almost exclusively in liver-derived cells. To overcome this limitation we used a cytomegalovirus promoter-controlled hepatitis B virus expression system, which leads to intracellular viral replication even in non-hepatic cell lines. In this experimental system interferon-alpha treatment specifically suppressed viral replication demonstrating that antiviral activities against hepatitis B virus are not restricted to hepatic cells. Furthermore, the interferon-inducible MxA protein was recently reported to play a key role in the antiviral action of interferon-alpha against hepatitis B virus. Our data demonstrate that interferon-alpha also suppresses hepatitis B virus replication in MxA-deficient HEp2 cells, indicating that MxA is not essential for these activities. Taken together, our data imply that the experimental approach presented can also be adapted to established cell lines which are deficient in parts of the signal transduction pathway or other elements located further downstream, providing important insights into mechanisms specifically suppressing hepatitis B virus.
Assuntos
Antivirais/farmacologia , Proteínas de Ligação ao GTP , Vírus da Hepatite B/metabolismo , Interferon-alfa/farmacologia , Proteínas/metabolismo , Southern Blotting , Western Blotting , Linhagem Celular , Dimerização , Humanos , Fígado/citologia , Proteínas de Resistência a Myxovirus , Plasmídeos/metabolismo , Ligação Proteica , Transdução de Sinais , Transfecção , Células Tumorais CultivadasRESUMO
The La protein was recently identified as a host factor potentially involved in the cytokine-induced post-transcriptional down-regulation of hepatitis B virus (HBV) RNA. The La binding site was mapped to a predicted stem-loop structure within a region shared by all HBV RNAs, and it was concluded that the La protein might be an HBV RNA-stabilizing factor. To characterize the RNA binding mediated by the different RNA recognition motifs (RRMs) of the human La protein, several La deletion mutants were produced and analyzed for HBV RNA binding ability. The data demonstrate that the first RRM is not required for binding, whereas the RNP-1 and RNP-2 consensus sequences of the RRM-2 and RRM-3 are separately required for binding, indicating a cooperative function of these two RRMs. Furthermore, the results suggest that multimeric La disassembles into monomeric La upon binding of HBV RNA.B. By gel retardation assay the affinity of the wild type human La.HBV RNA.B interaction was determined in the nanomolar range, comparable to the affinity determined for the mouse La.HBV RNA.B interaction. This study identified small regions within the human La protein mediating the binding of HBV RNA. Hence, these binding sites might represent targets for novel antiviral strategies based on the disruption of the human La.HBV RNA interaction, thereby leading to HBV RNA degradation.
Assuntos
Autoantígenos/genética , Vírus da Hepatite B/genética , RNA Viral/metabolismo , Proteínas de Ligação a RNA/genética , Ribonucleoproteínas/genética , Motivos de Aminoácidos , Sequência de Aminoácidos , Autoantígenos/química , Autoantígenos/metabolismo , Sequência de Bases , Primers do DNA , Humanos , Mutagênese , Ligação Proteica , Proteínas de Ligação a RNA/química , Proteínas de Ligação a RNA/metabolismo , Proteínas Recombinantes/química , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Ribonucleoproteínas/química , Ribonucleoproteínas/metabolismo , Antígeno SS-BRESUMO
The La protein is a multifunctional RNA-binding protein and has also been suggested to be involved in the stabilization of hepatitis B virus (HBV) RNA. Here we demonstrate that antibodies against the human La protein specifically precipitate HBV RNA from HBV ribonucleoprotein-containing mammalian cell extracts, providing evidence for the association between human La and HBV RNA. Moreover, we report that the turnover of HBV RNA depends on structural features and less on the primary sequence of the La-binding site on the viral RNA. In addition we show that the interaction between human La and HBV RNA in vitro is modulated by accessory factor(s) in a phosphorylation-dependent manner. Taken together these data indicate that both structural features, the composition of La/HBV ribonucleoprotein particles as well as interacting cellular factors, are critical determinants in the regulation of the stability of the HBV RNA.